Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

Catalyst (@CatalystForRare) / X

Therapeutic Focus: Rare Diseases - MM+M - Medical Marketing and Media

Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

GC Pharma signs to license for blood coagulation drug candidates

Paradigm Launches with $203M to Transform Clinical Trial

Dan Brennan on LinkedIn: Catalyst: A Biopharmaceutical Company

Jaymie Rodems on LinkedIn: Today is my official 1st day as the new

Unraveling the Future of Catalyst Pharmaceuticals Inc (CPRX): A

Catalyst Pharma Competitor Surprises With Positive Orphan Disease

Catalyst licenses Santhera Pharmaceuticals' vamorolone